Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator. Its mechanism of action involves direct relaxation of vascular smooth muscle, leading to vasodilation. It also exhibits some beta-adrenergic agonist activity, which may contribute to its effects.
## Primary Indications
* **Peripheral vascular disease:** Primarily used to improve blood flow in conditions such as intermittent claudication. Its efficacy in this indication is controversial and not well-established by robust clinical trials.
* **Cerebrovascular insufficiency:** Historically used, but evidence for efficacy is lacking.
* **Dysmenorrhea:** Limited evidence supports its use.
## Adult Dosing
The typical starting dose is 10 mg to 20 mg orally three to four times daily.
The dose may be gradually increased to 20 mg to 40 mg orally four times daily.
Maximum recommended daily dose is generally 160 mg.
Dosing may vary based on individual response and tolerability.
## Pediatric Dosing
Information on the use of isoxsuprine hydrochloride in pediatric patients is not established. Use is generally not recommended due to lack of safety and efficacy data.
## Dose Adjustments
No specific dose adjustments are routinely recommended for hepatic or renal impairment. However, caution should be exercised, and lower doses may be considered in patients with severe impairment due to potential accumulation.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Do not administer intravenously, as this route is associated with severe adverse reactions including marked hypotension and tachycardia.
## Adverse Effects
Common adverse effects include:
* Gastrointestinal: Nausea, vomiting, abdominal distress.
* Cardiovascular: Hypotension, tachycardia, dizziness, flushing.
* Neurological: Weakness, nervousness.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the effects of antihypertensive medications, potentially leading to excessive hypotension.
* **Other Vasodilators:** Concurrent use with other vasodilating agents may increase the risk of hypotension.
## Monitoring
* Blood pressure and heart rate should be monitored, especially at the initiation of therapy or with dose increases.
* Monitor for signs and symptoms of adverse effects.
* Assess for improvement in symptoms related to peripheral vascular disease, though clinical benefit is often difficult to ascertain.
## Clinical Pearls
* The clinical utility and efficacy of isoxsuprine hydrochloride in its primary indications are not well-supported by current evidence. It is often considered a drug with limited therapeutic value.
* Administer with meals to minimize gastrointestinal upset.
* Patients should be advised to rise slowly from a sitting or lying position to minimize orthostatic hypotension.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for definitive patient management decisions. This information does not replace professional medical judgment.*
